Page last updated: 2024-10-26

valproic acid and Angiohemophilia

valproic acid has been researched along with Angiohemophilia in 6 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"Valproic acid is commonly used in the management of childhood epilepsy."3.71Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid. ( Kavakli, K; Serdaroglu, G; Tekgül, H; Tütüncüoglu, S, 2002)
"Fibrinogen was significantly reduced."2.73High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study. ( Dempfle, CE; Gerstner, T; Keller, A; Koenig, S; Longin, E; Teich, M, 2008)
"Valproic acid (VPA) is an antiepileptic drug (AED) commonly used for generalized and focal epilepsies."1.33Valproate-associated coagulopathies are frequent and variable in children. ( Bell, N; Brand, J; Dempfle, CE; Gerstner, T; König, S; Longin, E; Teich, M, 2006)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koenig, S1
Gerstner, T2
Keller, A1
Teich, M2
Longin, E2
Dempfle, CE2
Eberl, W1
Budde, U1
Bentele, K1
Christen, HJ1
Knapp, R1
Mey, A1
Schneppenheim, R1
Bell, N1
Brand, J1
König, S1
Gil-Fernández, JJ1
Serdaroglu, G1
Tütüncüoglu, S1
Kavakli, K1
Tekgül, H1
Kreuz, W1
Linde, R1
Funk, M1
Meyer-Schrod, R1
Föll, E1
Nowak-Göttl, U1
Jacobi, G1
Vigh, Z1
Scharrer, I1

Trials

1 trial available for valproic acid and Angiohemophilia

ArticleYear
High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2008, Volume: 19, Issue:5

    Topics: Anticonvulsants; Blood Platelets; Child; Child, Preschool; Factor XIII; Female; Fibrinogen; Humans;

2008

Other Studies

5 other studies available for valproic acid and Angiohemophilia

ArticleYear
Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.
    Hamostaseologie, 2009, Volume: 29, Issue:2

    Topics: Anticonvulsants; Child; Factor VIII; Humans; Seizures; Valproic Acid; von Willebrand Diseases; von W

2009
Valproate-associated coagulopathies are frequent and variable in children.
    Epilepsia, 2006, Volume: 47, Issue:7

    Topics: Age Factors; Anticonvulsants; Blood Coagulation Tests; Child; Coagulation Protein Disorders; Epileps

2006
Analysis of surgical blood loss and number of blood transfusions after temporal lobe resection performed in adults with epilepsy receiving valproate (VPA) in the immediate preoperative period.
    Epilepsia, 1997, Volume: 38, Issue:11

    Topics: Adolescent; Adult; Aged; Bleeding Time; Blood Loss, Surgical; Blood Transfusion; Epilepsy, Temporal

1997
Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid.
    Journal of child neurology, 2002, Volume: 17, Issue:1

    Topics: Adolescent; Anticonvulsants; Antigens; Blood Coagulation Tests; Child; Child, Preschool; Dose-Respon

2002
Induction of von Willebrand disease type I by valproic acid.
    Lancet (London, England), 1990, Jun-02, Volume: 335, Issue:8701

    Topics: Adolescent; Child; Child, Preschool; Factor VIII; Female; Humans; Infant; Male; Valproic Acid; von W

1990